LeClair Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$214K Buy
+427
New +$205K 0.11% 125
2026
Q1
Sell
-397
Closed -$230K 184
2025
Q4
$230K Buy
+397
New +$225K 0.13% 100
2025
Q2
Sell
-410
Closed -$204K 103
2025
Q1
$204K Sell
410
-21
-5% -$11.4K 0.15% 94
2024
Q4
$224K Buy
+431
New +$237K 0.15% 90

Other funds holding TMO

LeClair Wealth Partners's TMO Position: Q2 2026 in Review

LeClair Wealth Partners opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 427 shares worth $214K. The stake represents 0.11% of the portfolio and ranks #125 among its holdings. This is a return to the name: LeClair Wealth Partners previously reported a position in TMO as recently as Q4 2025.

LeClair Wealth Partners first reported a position in TMO in Q4 2024 and has held it in 4 quarters since. The position peaked at $230K in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • LeClair Wealth Partners held 427 shares of Thermo Fisher Scientific worth $214K as of Q2 2026.
  • Thermo Fisher Scientific was a new LeClair Wealth Partners position in Q2 2026.
  • Thermo Fisher Scientific made up 0.11% of LeClair Wealth Partners's portfolio in Q2 2026, its #125 holding.
  • LeClair Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 4 quarters since.
  • LeClair Wealth Partners's Thermo Fisher Scientific position peaked at $230K in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on LeClair Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.